Hui‐Chien Kuo

2.6k total citations
18 papers, 549 citations indexed

About

Hui‐Chien Kuo is a scholar working on Molecular Biology, Epidemiology and Rheumatology. According to data from OpenAlex, Hui‐Chien Kuo has authored 18 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Rheumatology. Recurrent topics in Hui‐Chien Kuo's work include Cancer Cells and Metastasis (3 papers), Virus-based gene therapy research (2 papers) and Glioma Diagnosis and Treatment (2 papers). Hui‐Chien Kuo is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Virus-based gene therapy research (2 papers) and Glioma Diagnosis and Treatment (2 papers). Hui‐Chien Kuo collaborates with scholars based in United States, India and Germany. Hui‐Chien Kuo's co-authors include John B. Fiveash, G. Yancey Gillespie, James M. Markert, Burt Nabors, Richard J. Whitley, Jacqueline N. Parker, Matthias Karrasch, Bonita S. Agee, Jennifer Coleman and Anette Knoll and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Clinical Cancer Research.

In The Last Decade

Hui‐Chien Kuo

18 papers receiving 542 citations

Peers

Hui‐Chien Kuo

GENET

ONCOL

EPIDE

GENET

T Shikano Japan

Ghassan Alusi United Kingdom

M.K. Brenner United States

CA Mullen United States

Jörg Schüttrumpf Germany

Thomas B. Okarma United States

Bernice Lo United States

Ursula Holzer Germany

Ramakrishna Edukulla United States

Elizabeth Mroczek‐Musulman United States

T Shikano Japan

Hui‐Chien Kuo

255 ×1.0

GENET

227 ×1.0

ONCOL

216 ×1.1

65 ×0.5

EPIDE

63 ×0.8

GENET

Citations per year, relative to Hui‐Chien Kuo Hui‐Chien Kuo (= 1×) peers T Shikano

Countries citing papers authored by Hui‐Chien Kuo

Since Specialization

Citations

This map shows the geographic impact of Hui‐Chien Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Chien Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Chien Kuo more than expected).

Fields of papers citing papers by Hui‐Chien Kuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Chien Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Chien Kuo. The network helps show where Hui‐Chien Kuo may publish in the future.

Co-authorship network of co-authors of Hui‐Chien Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Chien Kuo. A scholar is included among the top collaborators of Hui‐Chien Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Chien Kuo. Hui‐Chien Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Chou, Chu‐Fang, Yun Huang, Jeremy B. Foote, et al.. (2025). Constitutive epidermal expression of osteopontin in osteopontin-null mice restores ultraviolet B-induced cutaneous squamous cell carcinomas to wild-type levels. Carcinogenesis. 46(4). 1 indexed citations

Kuo, Hui‐Chien, et al.. (2022). Screening and Referral Practices for Nonalcoholic Fatty Liver Disease by Race and Ethnicity in a Primary Care Clinic. Journal of Racial and Ethnic Health Disparities. 10(3). 1392–1397. 2 indexed citations

Khanna, Puja, Dinesh Khanna, Gary Cutter, et al.. (2021). Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial. Arthritis & Rheumatology. 73(8). 1523–1532. 37 indexed citations

Khanna, P. P., Dinesh Khanna, Gary Cutter, et al.. (2021). POS0135 REDUCING IMMUNOGENICITY OF PEGLOTICASE (RECIPE) WITH CONCOMITANT USE OF MYCOPHENOLATE MOFETIL IN PATIENTS WITH REFRACTORY GOUT: A PHASE II RANDOMIZED CONTROLLED TRIAL. Annals of the Rheumatic Diseases. 80. 279–280. 2 indexed citations

Travers, Colm P., Abigail E. Martin, Hui‐Chien Kuo, et al.. (2020). Non-invasive forced oscillometry to quantify respiratory mechanics in term neonates. Pediatric Research. 88(2). 293–299. 14 indexed citations

Kong, Michele, Wei Wei Zhang, Gregory S. Gorman, et al.. (2020). Azithromycin Treatment vs Placebo in Children With Respiratory Syncytial Virus–Induced Respiratory Failure. JAMA Network Open. 3(4). e203482–e203482. 14 indexed citations

Kuo, Hui‐Chien, et al.. (2019). A comparative analysis of documented contraceptive use among women aged 18–30 living with and without HIV in Alabama. Contraception. 100(4). 275–278. 1 indexed citations

Jiang, Chunsun, Hui‐Chien Kuo, Stephanie Wall, et al.. (2019). Cyclic O3 exposure synergizes with aging leading to memory impairment in male APOE ε3, but not APOE ε4, targeted replacement mice. Neurobiology of Aging. 81. 9–21. 13 indexed citations

Kuo, Hui‐Chien, et al.. (2018). P128 USE OF QUALITY IMPROVEMENT PROCESS TO INCREASE INFLUENZA VACCINATION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS. Gastroenterology. 154(1). S65–S65. 2 indexed citations

10.

Marsico, Concetta, Hui‐Chien Kuo, Scott H. James, et al.. (2018). Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection. The Journal of Infectious Diseases. 219(9). 1398–1406. 39 indexed citations

11.

Liu, Rui-Ming, Nobuo Watanabe, Jessy S. Deshane, et al.. (2015). Therapeutic potential of an orally effective small molecule inhibitor of plasminogen activator inhibitor for asthma. American Journal of Physiology-Lung Cellular and Molecular Physiology. 310(4). L328–L336. 11 indexed citations

12.

Markert, James M., Shantanu N. Razdan, Hui‐Chien Kuo, et al.. (2014). A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses. Molecular Therapy. 22(5). 1048–1055. 240 indexed citations

13.

Amm, Hope M., Tong Zhou, Adam D. Steg, et al.. (2011). Mechanisms of Drug Sensitization to TRA-8, an Agonistic Death Receptor 5 Antibody, Involve Modulation of the Intrinsic Apoptotic Pathway in Human Breast Cancer Cells. Molecular Cancer Research. 9(4). 403–417. 25 indexed citations

14.

Juliana, M. Margaret, et al.. (2011). Host‐derived osteopontin maintains an acute inflammatory response to suppress early progression of extrinsic cancer cells. International Journal of Cancer. 131(2). 322–333. 12 indexed citations

15.

Nabors, Burt, John B. Fiveash, James M. Markert, et al.. (2010). A Phase 1 Trial of ABT-510 Concurrent With Standard Chemoradiation for Patients With Newly Diagnosed Glioblastoma. Archives of Neurology. 67(3). 313–9. 51 indexed citations

16.

Yu, Hongying, et al.. (2010). More than regulation of skewed Th1/Th2 cytokines in allergic asthma: A case treated with omalizumab. Paediatric Respiratory Reviews. 11. S83–S83. 1 indexed citations

17.

Kimball, Kristopher J., Meredith A. Preuss, Mack N. Barnes, et al.. (2010). A Phase I Study of a Tropism-Modified Conditionally Replicative Adenovirus for Recurrent Malignant Gynecologic Diseases. Clinical Cancer Research. 16(21). 5277–5287. 81 indexed citations

18.

Fiveash, John B., James M. Markert, G. Yancey Gillespie, et al.. (2009). A phase I study of ABT 510 and concurrent temozolamide and radiotherapy for patients with newly diagnosed glioblastoma multiforme. Journal of Clinical Oncology. 27(15_suppl). 2023–2023. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact